首页0460 • HKG
add
四环医药控股集团有限公司
市场资讯
财务信息
损益表
收入
净收入
| (CNY) | 2023年12月info | 年同比变化 |
|---|---|---|
收入 | 4.02亿 | — |
经营支出 | 3.74亿 | — |
净收入 | -218.65万 | — |
净利润率 | -0.54 | — |
每股收益 | — | — |
息税折旧摊销前利润 | -6435.50万 | — |
有效税率 | -8.22% | — |
资产负债表
总资产
负债总额
| (CNY) | 2023年12月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 43.68亿 | -8.85% |
总资产 | 115.35亿 | -4.98% |
负债总额 | 63.98亿 | -1.57% |
权益总额 | 51.37亿 | — |
发行在外的股份 | 92.82亿 | — |
市净率 | 1.17 | — |
资产回报率 | -2.18% | — |
资本回报率 | -3.93% | — |
现金流
现金净变动
| (CNY) | 2023年12月info | 年同比变化 |
|---|---|---|
净收入 | -218.65万 | — |
来自运营的现金 | 8558.45万 | — |
投资现金 | 3475.80万 | — |
融资现金 | -9802.55万 | — |
现金净变动 | 2231.70万 | — |
自由现金流 | -1.10亿 | — |
简介
Sihuan Pharmaceutical is a Chinese pharmaceutical manufacturer with headquarters in Beijing and branch office in Haikou, Hainan Province. The main company in the group is the holding company Sihuan Pharmaceutical Holdings Group Ltd, which is listed on the Hong Kong stock market.
Sihuan Pharmaceutical is collaborating with the Academy of Military Medical Science in the development of the drug JK-05, intended for the treatment of Ebola virus disease. The company has been challenged by Fujifilm Holdings Corporation, which has stated that JK-05 infringes its patent rights regarding Avigan. Wikipedia
CEO
成立时间
2001
员工数量
2,872
